Medicines and Tax Notices




24 MAY

NEW ZEALAND GAZETTE

1181

Flixotide Rotadisk

Active Ingredient(s): Fluticasone propionate 250µg

Dosage Form: Powder for inhalation

New Zealand Sponsor: Glaxo Wellcome New Zealand Limited

Manufacturer(s): Glaxo Wellcome Production, Evreux, France

Flixotide Rotadisk

Active Ingredient(s): Fluticasone propionate 50µg

Dosage Form: Powder for inhalation

New Zealand Sponsor: Glaxo Wellcome New Zealand Limited

Manufacturer(s): Glaxo Wellcome Production, Evreux, France

Flixotide Rotadisk

Active Ingredient(s): Fluticasone propionate 500µg

Dosage Form: Powder for inhalation

New Zealand Sponsor: Glaxo Wellcome New Zealand Limited

Manufacturer(s): Glaxo Wellcome Production, Evreux, France

Flixotide

Active Ingredient(s): Fluticasone propionate 25µg/dose

Dosage Form: Aerosol inhaler, metered dose

New Zealand Sponsor: Glaxo Wellcome New Zealand Limited

Manufacturer(s): Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia
Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France

Dated this 15th day of May 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go3473

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Copaxone

Active Ingredient(s): Glatiramer acetate 20mg

Dosage Form: Powder for injection

New Zealand Sponsor: Aventis Pharma Limited

Manufacturer(s): Teva Pharmaceutical Industries Limited, (Ikapharm) Kfar Saba, Israel

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 16th day of May 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go3475

Inland Revenue

Income Tax Act 1994

National Average Market Values of Specified Livestock Determination 2001

This determination may be cited as “The National Average Market Values of Specified Livestock Determination, 2001”.

This determination is made in terms of section EL 8 (1) of the Income Tax Act 1994 and shall apply to specified livestock on hand at the end of the 2000-2001 income year.

For the purposes of section EL 8 (1) of the Income Tax Act 1994, the national average market values of specified livestock for the 2000-2001 income year, are as set out in the following table.

Type of Livestock Classes of Livestock Average Market Value per Head $
Sheep Ewe hoggets 63
Ram and wether hoggets 61
Two-tooth ewes 72
Mixed-age ewes (rising three-year and four-year old ewes) 64
Rising five-year and older ewes 54
Mixed-age wethers 46
Breeding rams 134
Beef cattle Beef breeds and beef crosses:
Rising one-year heifers 423
Rising two-year heifers 667


Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 52


Gazette.govt.nz PDF NZ Gazette 2001, No 52





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines (continued from previous page)

🏥 Health & Social Welfare
15 May 2001
Medicines Act 1981, changed medicines, distribution consent, Flixotide Rotadisk, Fluticasone propionate
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Provisional Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
16 May 2001
Medicines Act 1981, provisional consent, new medicine, Copaxone, Glatiramer acetate
  • G. R. Boyd, Chief Advisor, Safety and Regulation

💰 National Average Market Values of Specified Livestock Determination 2001

💰 Finance & Revenue
Income Tax Act 1994, livestock valuation, sheep, beef cattle